Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide

Clinical trial NCT05023941 · COMPLETED

Trial details

NCT number: NCT05023941
Sponsor: Ji Xunming,MD,PhD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Mountain Sickness

Start date: 2021-12-01
Primary completion: 2022-08-22
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.